Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.
Akihide
A
Yoshimi
Go
G
Yamamoto
Tadashi
T
Goto
Kazuhiko
K
Koike
Mineo
M
Kurokawa
D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000601:surgery / Q000628:therapy; D017115:Catheter Ablation; D002908:Chronic Disease; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D004621:Embolization, Therapeutic; D004932:Esophageal and Gastric Varices / Q000175:diagnosis / Q000209:etiology; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications* / Q000188:drug therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015466:Leukemia, Myeloid, Chronic-Phase / Q000601:surgery*; D008103:Liver Cirrhosis / Q000150:complications* / Q000175:diagnosis; D008113:Liver Neoplasms / Q000209:etiology* / Q000601:surgery / Q000628:therapy; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology*; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone